All The World's News
Recent News Headlines : Eli Lilly
TRUMP'S HHS PICK RECENTLY WORKED FOR GROUPS SUING TO KEEP DRUG PRICING SECRET
In total, according to the Center for Responsive Politics, Eli Lilly has reported spending 5.7 million on lobbying efforts so far in 2017... READ MORE›
AS HE CHAIRS TRUMP'S OPIOID COMMISSION, CHRISTIE CHAMPIONS HIS HOME-STATE DRUG COMPANIES
As he chairs Trump's opioid commission, Christie champions his home-state drug companies... READ MORE›
TRUMP ADDS WELFARE REFORM TO HIS ALREADY FULL PLATE
We are looking very, very strongly, therefore, at welfare reform, Trump said at the White House as he met with his cabinet... READ MORE›
HURRICANE MARIA BRINGS DRUG MANUFACTURING TO A HALT IN PUERTO RICO
Hurricane Maria halts crucial drug manufacturing in Puerto Rico, may spur shortages... READ MORE›
Trending News Headlines : Eli Lilly
BERNIE SANDERS' DRUG PRICE BILL WOULD SAVE BILLIONS, CONGRESSIONAL ANALYSTS SAY
Spending millions on campaign donations and lobbying, the pharmaceutical industry has for years successfully fought off legislation to end the prohibition... READ MORE›
TRUMP POISED TO NOMINATE SCOTT GOTTLIEB TO HEAD FDA
Between 2005 and 2007 Gottlieb was FDA deputy commissioner for medical and scientific affairs... READ MORE›
CVS HEALTH IS SUED OVER 'CLAWBACKS' OF PRESCRIPTION DRUG CO-PAYS
And CVS Caremark, according to the suit filed Monday in federal court in Rhode Island... READ MORE›
BERNIE SANDERS TELLS BIG PHARMA: STOP MAKING AMERICANS PAY TWICE
In 1989, NIH was granted the right to review the introductory prices of drugs that were produced with government research, over the objections of the pharmaceutical industry... READ MORE›
TRUMP HAS PROMISED TO KILL OBAMACARE
What Will Health Care Look Like Under Donald Trump? one headline in the morning news wondered... READ MORE›
TRUMP SENDS PHARMA STOCKS DOWN WITH NEW TWEET ON DRUG PRICES
J J reversed earlier losses and was up 0.1 percent, and Merck dropped 0.5 percent... READ MORE›
DRUGS FIRMS ARE ACCUSED OF PUTTING CANCER PATIENTS AT RISK OVER PRICE HIKES
Academics say the prices of 14 cancer drugs have increased by between 100 percent and nearly 1,000 percent over the past five years in the UK... READ MORE›
PFIZER, ALLERGAN DRUG MERGER TALKS RAISE TAX HACKLES IN U.S.
Earlier Thursday before the companies confirmed the talks, Pfizer Chief Executive Officer Ian Read reiterated his criticism of U.S... READ MORE›
PAMPLONA CAPITAL TO TAKE PAREXEL PRIVATE FOR $4.5 BILLION
Pamplona will pay 88.10 per share in cash for Parexel, representing a 5 percent premium to the stock's Monday close... READ MORE›
ALLEGED SCHEME TO FIX GENERIC-DRUG PRICES STARTED AS DINNERS AND 'GIRLS NIGHTS OUT'
While wining and dining, drug-company employees conspired to keep prices high, according to a complaint filed by attorneys general of 20 states, including Washington... READ MORE›
BIG PHARMA LIMITING ACCESS TO DRUGS IN DEVELOPING WORLD
Nevertheless, Forbes reports that the pharmaceutical industry's average profit margin is almost 20 percent, exceeding that of banks, the oil and gas industries, and the media... READ MORE›
BEIJING BUYERS CLUB? CHINA'S CANCER PATIENTS GAMBLE ON GRAY MARKET
The overall 5-year survival rate for cancer in China is just over 30 percent, less than half the level in the United States, according to Deutsche Bank... READ MORE›
PHARMACEUTICAL FIRMS SPEND 40M A YEAR FOR 'PRIVILEGED ACCESS' TO EU DECISION-MAKERS
He has previously worked for the European Voice Daily Mirror and the Observer and been based in Brussels Belfast Tokyo and London... READ MORE›
MITSUBISHI TANABE PHARMA TO BUY ISRAEL'S NEURODERM FOR $1.1 BILLION
Mitsubishi Tanabe Pharma will pay 39 for each Neuroderm share, a premium of about 17 percent to its Friday close... READ MORE›
BIG PHARMA FIGHTS 'TOOTH AND NAIL' AGAINST CALIFORNIA DRUG VOTE
VA rates may be about 20 percent lower than Medicaid's, according to Piper Jaffray analyst Joshua Schimmer... READ MORE›
INC RESEARCH TO BUY INVENTIV IN LATEST CONTRACT MEDICAL RESEARCH DEAL
InVentiv, which is equally owned by private equity firms Advent International and Thomas H. Lee Partners, works with larger firms, including the top 20 biopharmaceutical companies... READ MORE›
NEW HEALTHCARE LAW IS A WIN FOR LOBBYISTS AND DRUG COMPANIES
Some, but not all of Bosarge's requests were integrated into the final version of the 21st Century Cures Act... READ MORE›
EXCLUSIVE: MCCONNELL EXPECTS BIPARTISAN SUPPORT FOR BILL REAUTHORIZING FDA USER FEES
Reauthorization of the user fee bill is typically negotiated between the FDA and industry over a period of several years... READ MORE›
DRUG SHARES TUMBLE ON TRUMP'S TALK OF PRICE CONTROLS
Donald Trump just created a big headache for Big Pharma... READ MORE›
NOVARTIS LOOKS TO WORLD'S RICH TO MEET NEED IN CHRONIC AILMENTS
Abraaj's health-care fund plans investments in hospitals and clinics among poorer neighborhoods in Nairobi, Lagos and Addis Ababa... READ MORE›
INFAMOUS 'PHARMA BRO' MARTIN SHKRELI CHARGED WITH FRAUD IN NEW YORK
Martin Shkreli, 32, allegedly defrauded investors in two hedge funds he founded and in Retrophin, a pharmaceutical firm he previously led... READ MORE›
SENATOR BERNIE SANDERS OFFERS BILL TO ALLOW DRUG IMPORTS FROM CANADA
A drug importation amendment was previously advanced during the budget resolution vote in the Senate in January... READ MORE›
'I AM RUNNING A FOR-PROFIT BUSINESS'
Raking it in Bresch's rising salary has also fueled anger over the EpiPen price increase... READ MORE›
MULTIBILLION-DOLLAR LOBBYING CAUSED DARAPRIM PRICE HIKE
He would require generic drug companies to rebate money to the government if their prices go up higher than inflation... READ MORE›
PHARMA GIANTS' STOCK PRICES HIT BY ANOTHER TRUMP TWEET
The price-gouging owner of Epipen, in which it has a 3.9 percent stake... READ MORE›
FRENCH DRUG TRIAL DISASTER LEAVES ONE BRAIN DEAD, FIVE INJURED[1]
French Health Minister Marisol Touraine and Gilles Hedan, professor of clinical neurology, attend a news conference in Rennes, France, Jan 15, 2016... READ MORE›
CLINTON ANNOUNCES PLAN TO ADDRESS 'UNJUSTIFIED' PRICE HIKES ON LIFE-SAVING DRUGS
Bach said he was contacted by the Clinton campaign about his work on drug pricing but had not advised the campaign in a formal capacity... READ MORE›
BUSH-ERA FDA OFFICIAL IS TRUMP'S CHOICE TO LEAD AGENCY
Scott Gottlieb, a partner at a venture capital fund, is reportedly set to be nominated to lead the Food and Drug Administration... READ MORE›
FTC APPROVES ENDO'S PURCHASE OF PAR PHARMACEUTICALS WITH TWO DIVESTMENTS
Antitrust approval to buy Par Pharmaceuticals Inc on condition that it divest two generic medicines the Federal Trade Commission said on Friday... READ MORE›
DISGRACED EPIPEN MAKER GAVE $10K TO SCHUMER CAMPAIGN IN JUNE
Disgraced EpiPen maker gave 10K to Schumer campaign in June... READ MORE›